Lindbrook Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $61.1K | Buy |
492
+103
| +26% | +$12.8K | 0.01% | 906 |
|
2024
Q4 | $47.9K | Buy |
389
+176
| +83% | +$21.7K | ﹤0.01% | 831 |
|
2024
Q3 | $23.7K | Buy |
213
+45
| +27% | +$5.01K | ﹤0.01% | 1200 |
|
2024
Q2 | $17.9K | Buy |
168
+33
| +24% | +$3.52K | ﹤0.01% | 1306 |
|
2024
Q1 | $16.3K | Sell |
135
-3
| -2% | -$361 | ﹤0.01% | 1322 |
|
2023
Q4 | $17K | Sell |
138
-22
| -14% | -$2.71K | ﹤0.01% | 1272 |
|
2023
Q3 | $20.7K | Buy |
160
+5
| +3% | +$647 | ﹤0.01% | 1045 |
|
2023
Q2 | $19.2K | Sell |
155
-45
| -23% | -$5.58K | ﹤0.01% | 1111 |
|
2023
Q1 | $29.3K | Buy |
200
+42
| +27% | +$6.15K | ﹤0.01% | 897 |
|
2022
Q4 | $25.2K | Buy |
158
+63
| +66% | +$10K | ﹤0.01% | 955 |
|
2022
Q3 | $13K | Hold |
95
| – | – | ﹤0.01% | 1200 |
|
2022
Q2 | $15K | Hold |
95
| – | – | ﹤0.01% | 1097 |
|
2022
Q1 | $15K | Buy |
95
+4
| +4% | +$632 | ﹤0.01% | 1128 |
|
2021
Q4 | $12K | Buy |
91
+59
| +184% | +$7.78K | ﹤0.01% | 1201 |
|
2021
Q3 | $4K | Buy |
32
+3
| +10% | +$375 | ﹤0.01% | 1314 |
|
2021
Q2 | $5K | Buy |
29
+8
| +38% | +$1.38K | ﹤0.01% | 1288 |
|
2021
Q1 | $3K | Hold |
21
| – | – | ﹤0.01% | 1421 |
|
2020
Q4 | $3K | Sell |
21
-37
| -64% | -$5.29K | ﹤0.01% | 1341 |
|
2020
Q3 | $8K | Buy |
58
+21
| +57% | +$2.9K | ﹤0.01% | 912 |
|
2020
Q2 | $4K | Buy |
37
+18
| +95% | +$1.95K | ﹤0.01% | 1171 |
|
2020
Q1 | $2K | Sell |
19
-22
| -54% | -$2.32K | ﹤0.01% | 1297 |
|
2019
Q4 | $6K | Hold |
41
| – | – | ﹤0.01% | 1062 |
|
2019
Q3 | $5K | Hold |
41
| – | – | ﹤0.01% | 1069 |
|
2019
Q2 | $5K | Buy |
41
+19
| +86% | +$2.32K | ﹤0.01% | 1061 |
|
2019
Q1 | $3K | Hold |
22
| – | – | ﹤0.01% | 1162 |
|
2018
Q4 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 1173 |
|